Permanent in vitro growth is associated with poor prognosis in head and neck cancer

Acta Oto-Laryngologica

Volumn 124, Issue 2, 2004, Pages 192-196

  Pekkola, K ^a   Raikka A ^a   Joensuu, H ^b   Minn, H ^a   Aitasalo, K ^a   Grenman, R ^a,c  

^a TURKU UNIVERSITY HOSPITAL   (Finland)

^b HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^c UNIVERSITY OF TURKU   (Finland)

Author keywords

Cell line growth; Head and neck cancer; Survival

Indexed keywords

ADULT; AGE; AGED; ARTICLE; CANCER CELL CULTURE; CANCER GRADING; CANCER GROWTH; CANCER SURVIVAL; CLINICAL ARTICLE; CLINICAL PROTOCOL; CONTROLLED STUDY; FEMALE; FOLLOW UP; GENDER; GENERAL CONDITION; HEAD AND NECK CANCER; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; MALE; METASTASIS; MULTIVARIATE ANALYSIS; OUTCOMES RESEARCH; PARACRINE SIGNALING; PRIORITY JOURNAL; PROGNOSIS; SURVIVAL RATE; SURVIVAL TIME; TUMOR CELL CULTURE; TUMOR CELL LINE; TUMOR LOCALIZATION;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, SQUAMOUS CELL; CASE-CONTROL STUDIES; CELL DIVISION; CELL LINE, TUMOR; FEMALE; HEAD AND NECK NEOPLASMS; HUMANS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PROGNOSIS; RETROSPECTIVE STUDIES; SURVIVAL RATE;

EID: 12144287733     PISSN: 00016489     EISSN: None     Source Type: Journal    
DOI: 10.1080/00016480310015209     Document Type: Article

References (25)

1. Krause CJ, Carey TE, Russell WO, Hurbis C, McClatchey KD, Regezi JA. Human squamous cell carcinoma. Establishment and characterization of new permanent cell lines. Arch Otolaryngol 1981; 107: 703-10.
2. Grénman R, Pekkola-Heino K. In vitro radiosensitivity - a prognostic marker? In: Werner JA, Lippert BM, Rudert HH, editors. Head and neck cancer: advances in basic research. Proceedings of the International Symposium on Advances in Head and Neck Cancer, Kiel, Germany, 18-20 January, 1996. Amsterdam: Elsevier; 1996. p. 497-503.
3. Lansford CD, Grénman R, Bier H, et al. Head and neck cancers. In: Masters J, Palsson B, editors. Human cell culture, Vol. 2, Cancer cell lines, Part 2. Dordrecht, The Netherlands: Kluwer Academic Press; 1999. p. 185-255.
4. Yves D, Ghossein NA. Experience of the Curie Institute in treatment of cancer of the mobile tongue I. Cancer 1981; 47: 496.
5. Wang CC. Radiation therapy for the head and neck neoplasms: indications, techniques, and results. Boston, MA: John Wright PSG; 1983.
6. Baker SR. Malignant neoplasms of the oral cavity. In: Cummings W, Fredrickson J, Harker L, Krause CH, Richardson M, Schuller D, editors. Otolaryngology - head and neck surgery. St. Louis, MO: Mosby; 1998. p. 1418.
7. Adams GL, Carlson RD. Malignant neoplasms of the larynx. In: Cummings W, Fredrickson J, Harker L, Krause CH, Richardson M, Schuller D, editors. Otolaryngology - head and neck surgery. St. Louis, MO: Mosby; 1998. p. 2130.
8. Zätterström UK, Wennerberg J, Ewers SB, Willen R, Attewell R. Prognostic factors in head and neck cancer: histologic grading, DNA ploidy and nodal status. Head Neck 1991; 13: 477-87.
9. Pekkola-Heino K, Kulmala J, Klemi P, et al. Effects of radiation fractionation on four squamous cell carcinoma lines with dissimilar inherent radiation sensitivity. J Cancer Res Oncol Clin 1991; 117: 597-602.
10. Girinsky T, Bernheim A, Lubin R, et al. In vitro parameters and treatment outcome in head and neck cancers treated with surgery and/or radiation: cell characterization and overall survival. Int J Radiat Oncol Biol Phys 1994; 30: 789-94.
11. West CML. Intrinsic radiosensitivity as a predictor of patient response to radiotherapy. Br J Radiol 1995; 68: 827-37.
12. Girinsky T, Lubin R, Pignon JP, et al. Predictive value of in vitro radiosensitivity parameters in head and neck cancers and cervical carcinomas: preliminary correlations with local control and overall survival. Int J Radiat Oncol Biol Phys 1993; 25: 3-7.
13. Roland NJ, Caslin AW Nash J, Stell PM. Value of grading squamous cell carcinoma of the head and neck. Head Neck 1991; 14: 224-9.
14. Overgaard J, Hansen HS, Jörgensen K, Hjelm-Hansen M. Primary radiotherapy of larynx and pharynx carcinoma - an analysis of some factors influencing local control and survival. Int Radiat Oncol Biol Phys 1986; 12: 515-21.
15. Bryne M, Eide GE, Lilleng R, Langmark F, Thrane PS, Dabelsteen E. A multivariate study of the prognosis of oral squamous cell carcinomas. Are blood group and hemoglobin new prognostic factors? Cancer 1991; 68: 1994-8.
16. van Acht MJ, Hermans J, Boks DE, Leer JW The prognostic value of hemoglobin and a decrease in hemoglobin during radiotherapy in laryngeal carcinoma. Radiother Oncol 1992; 23: 229-35.
17. Fietkau R, Iro H, Tulusan AH, Dressel V, Altendorf-Hofman A, Sauer R. Prognostic value of S-phase fraction in head and neck squamous cell carcinoma and nodal negative breast carcinomas. Strahlender Onkol 1994; 170: 13-24.
18. Dubray B, Mosseri V, Brunin F, et al. Anemia is associated with lower local-regional control and survival after radiation therapy for head and neck cancer: a prospective study. Radiology 1996; 201: 553-8.
19. Goldsmith MM, Cresson DH, Arnold LA, Duncan SP, Askin FB, Pillsbury HC. DNA flow cytometry as a prognostic indicator in head and neck cancer. Otolaryngol Head Neck Surg 1987; 96: 307-18.
20. Kokal WA, Gardine RI, Sheibani K, et al. Tumor DNA content as a prognostic indicator in squamous cell carcinoma of the head and neck region. Am J Surg 1988; 156: 277-80.
21. Guo YC, DeSanto L, Osetinsky GV. Prognostic implications of nuclear DNA content in head and neck cancer. Otolaryngol Head Neck Surg 1989; 100: 95-8.
22. Kearsley JH, Bryson G, Battistutta D, Collins RJ. Prognostic importance of cellular DNA content in head and neck squamous cell cancers. A comparison of retrospective and prospective series. Int J Cancer 1991; 47: 31-7.
23. Lampe HB. DNA analysis of head and neck squamous cell carcinoma by flow cytometry. Laryngoscope 1993; 103: 637-44.
24. Welkoborsky HJ, Hinni M, Dienes HP, Mann WJ. Predicting recurrence and survival in patients with laryngeal cancer by means of DNA cytometry, tumor front grading, and proliferation markers. Ann Otol Rhinol Laryngol 1995; 104: 503-10.
25. Akervall JA, Jin Y, Wennerberg JP, et al. Chromosomal abnormalities involving 11q13 are associated with poor prognosis in patients with squamous cell carcinoma of the head and neck. Cancer 1995; 76: 853-9.